How are the Premier's Awards helping cancer researchers?
2 May 2019
The Premier’s Awards not only recognise the state’s top cancer researchers but also propels their work to greater heights.
Hear from the 2017 winners and find out how it is influencing their work:
Melanoma Translational Research Team
– Wildfire Highly Cited Publication Award
The award is allowing Professor Rizos’ team to extend their research into regulating melanoma gene expression and its role in the response of melanoma to immunotherapy.
Melanoma Institute Australia
– Excellence in Translational Cancer Research Award
The award is supporting a plethora of Melanoma Institute Australia research projects that made headlines around the world. These include discovering the specific mechanisms behind immune-mediated equilibrium
Professor Scolyer and Professor Long won major awards at the 2018
– Outstanding Cancer Researcher of the Year Award
Professor Kefford’s is commissioning a tailor-made, melanoma-specific gene mutation panel for DNA sequencing machinery in their laboratory. The award is enabling his team to extend their research into regulating melanoma gene expression and its role in the response of melanoma to immunotherapy.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.